Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs-Reference-Cited by-同舟云学术

Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs

Published:1991-09 Issue:1 Volume:90 Page:31-37
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Matsunaga Akira,Sasaki Jun,Takada Yoichi,Hidaka Kazuko,Arakawa Kikuo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Competitive inhibition of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity;Endo;FEBS Lett.,1976

2. Therapeutic effects of ML-236B in primary hypercholesterolemia;Yamamoto;Atherosclerosis,1981

3. Effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia;Mabuchi;N. Engl. J. Med.,1981

4. Mevinolin in the therapy of heterozygous familial hypercholesterolemia;Illingworth;Circulation,1983

5. Mevinolin and colestipol stimulate receptor mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes;Bilheimer,1983

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin treatment increases lipoprotein(a) levels in subjects with low molecular weight apolipoprotein(a) phenotype;Atherosclerosis;2019-10

2. A Genomic DNA Reporter Screen Identifies Squalene Synthase Inhibitors That Act Cooperatively with Statins to Upregulate the Low-Density Lipoprotein Receptor;Journal of Pharmacology and Experimental Therapeutics;2017-03-30

3. Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment;Neurobiology of Disease;2007-02

4. Guinea Pigs as Models to Study the Hypocholesterolemic Effects of Drugs;Cardiovascular Drug Reviews;2006-06-07

5. Syntheses of 3-Ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels;Bioorganic & Medicinal Chemistry;2003-08